Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3NIH 3NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3

Conditions

Leukemia, Myeloid, Acute 76Precursor Cell Lymphoblastic Leukemia-Lymphoma 52Leukemia 36Lymphoma 9Leukemia, Monocytic, Acute 9Leukemia, Erythroblastic, Acute 8Leukemia, Myelomonocytic, Acute 7Leukemia, Megakaryoblastic, Acute 7Burkitt Lymphoma 7Neoplasm, Residual 6Myelodysplastic Syndromes 6Congenital Abnormalities 6Leukemia, Biphenotypic, Acute 4Recurrence 3Leukemia, Promyelocytic, Acute 3Anemia, Refractory, with Excess of Blasts 3Thrombocythemia, Essential 2Primary Myelofibrosis 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Polycythemia Vera 2Philadelphia Chromosome 2Myeloproliferative Disorders 2Lymphoma, Non-Hodgkin 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Down Syndrome 2Dendritic Cell Sarcoma, Interdigitating 2Thrombocytopenia 1Sarcoma 1

Interventions

Arsenic Trioxide 21Tretinoin 20Cytarabine 12Cyclophosphamide 11Busulfan 10Methotrexate 9Idarubicin 9Filgrastim 8fludarabine phosphate 7Peripheral Blood Stem Cell Transplantation 6Tacrolimus 5Gemtuzumab 5Etoposide 5Radiotherapy 4Clofarabine 4Antilymphocyte Serum 4Topotecan 3Mycophenolic Acid 3Mitoxantrone 3Mercaptopurine 3Daunorubicin 3venetoclax 2lintuzumab 2Whole-Body Irradiation 2Thiotepa 2Sorafenib 2Granulocyte Colony-Stimulating Factor 2Cyclosporins 2Cyclosporine 2Carboplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Leukemia, Promyelocytic, Acute × Daunorubicin × Clear all
NCT05832320 2024-05-10

Optimum Induction Therapy of Low-risk APL

Peking University People's Hospital

Phase NA Unknown
74 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT00276601 2014-04-17

Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

NCT00180128 2011-07-11

AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia

Technische Universität Dresden

Phase 4 Unknown
80 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡